Submitted on October 16, 2015 - USP Comment Letter to FDA on Botanical Drug Development Draft Guidance for industry. Docket Number FDA-2000-D-0103.
Submitted on October 16, 2015 - USP Comment Letter to FDA on Botanical Drug Development Draft Guidance for industry. Docket Number FDA-2000-D-0103.